Stifel Nicolaus analyst Mathew Blackman reiterated a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...
Omega Healthcare Investors Inc. 0.95% $9.97B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback